DNA damage and augmented oxidative stress in bone marrow mononuclear cells from angiotensin-dependent hypertensive mice

International Journal of Hypertension

Volumn 2013, Issue , 2013, Pages

  Campagnaro, Bianca P ^a   Tonini, Clarissa L ^a   Nogueira, Breno V ^a   Casarini, Dulce E ^b   Vasquez, Elisardo C ^a,c   Meyrelles, Silvana S ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ETHIDIUM; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANIMAL CELL; ARTERY CLAMP; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; BONE MARROW; CELL ISOLATION; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; HEART; HEART RATE; HEMODYNAMIC PARAMETERS; HYPERTENSION; KIDNEY MASS; LYMPHOCYTE COUNT; MALE; MONONUCLEAR CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION;

EID: 84874926101     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2013/305202     Document Type: Article

References (79)

1. Faselis C., Doumas M., Papademetriou V., Common secondary causes of resistant hypertension and rational for treatment. International Journal of Hypertension 2011 2011 17 236239 10.4061/2011/236239
2. Nogueira B. V., Palomino Z., Porto M. L., Granulocyte colony stimulating factor prevents kidney infarction and attenuates renovascular hypertension. Cellular Physiology and Biochemistry 2012 29 1-2 143 152 10.1159/000337595
3. Gava A. L., Peotta V. A., Cabral A. M., Vasquez E. C., Meyrelles S. S., Overexpression of eNOS prevents the development of renovascular hypertension in mice. Canadian Journal of Physiology and Pharmacology 2008 86 7 458 464 2-s2.0-46749102818 10.1139/Y08-044 (Pubitemid 351948685)
4. Peotta V. A., Gava A. L., Vasquez E. C., Meyrelles S. S., Evaluation of baroreflex control of heart rate in renovascular hypertensive mice. Canadian Journal of Physiology and Pharmacology 2007 85 8 761 766 2-s2.0-36349021352 10.1139/Y07-067 (Pubitemid 350144735)
5. Nogueira B. V., Peotta V. A., Meyrelles S. S., Vasquez E. C., Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice. Archives of Medical Research 2007 38 8 816 821 2-s2.0-34848924371 10.1016/j.arcmed.2007.06.005 (Pubitemid 47513267)
6. Cheng H. F., Becker B. N., Burns K. D., Harris R. C., Angiotensin II upregulates type-1 angiotensin II receptors in renal proximal tubule. The Journal of Clinical Investigation 1995 95 5 2012 2019 2-s2.0-0028931708
7. Cohn J. N., Tognoni G., A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. The New England Journal of Medicine 2001 345 23 1667 1675 2-s2.0-0035818884 10.1056/NEJMoa010713 (Pubitemid 33126822)
8. Ruiz-Ortega M., Lorenzo O., Rupérez M., Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 2001 38 6 1382 1387 10.1161/hy1201.100589 (Pubitemid 34033420)
9. Strawn W. B., Richmond R. S., Ann Tallant E., Gallagher P. E., Ferrario C. M., Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells. British Journal of Haematology 2004 126 1 120 126 2-s2.0-3042748331 10.1111/j.1365-2141.2004.04998.x (Pubitemid 38859492)
10. Park T. S., Zambidis E. T., A role for the renin-angiotensin system in hematopoiesis. Haematologica 2009 94 6 745 747 2-s2.0-66749168189 10.3324/haematol.2009.006965
11. Wu T. C., Chao C. Y., Lin S. J., Low-dose dextromethorphan, a NADPH oxidase inhibitor, reduces blood pressure and enhances vascular protection in experimental hypertension. PLoS ONE 2012 7 9 e46067 10.1371/journal.pone.0046067
12. Ceron C. S., Castro M. M., Rizzi E., Montenegro M. F., Fontana V., Salgado M. C. O., Gerlach R. F., Tanus-Santos J. E., Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. British Journal of Pharmacology 2010 160 1 77 87 2-s2.0-77950930269 10.1111/j.1476-5381.2010.00678.x
13. Haznedaroglu I. C., Ozturk M. A., Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. The International Journal of Biochemistry and Cell Biology 2003 35 6 867 880 10.1016/S1357-2725(02)00278-9 (Pubitemid 36379328)
14. phox- dependent manner. Journal of Hypertension 2008 26 2 257 268 2-s2.0-38149097070 10.1097/HJH.0b013e3282f09f79
15. Sachse A., Wolf G., Angiotensin II-induced reactive oxygen species and the kidney. Journal of the American Society of Nephrology 2007 18 9 2439 2446 2-s2.0-34548496478 10.1681/ASN.2007020149 (Pubitemid 47378859)
16. Wolf G., Role of reactive oxygen species in angiotensin II-mediated renal growth, differentiation, and apoptosis. Antioxidants and Redox Signaling 2005 7 9-10 1337 1345 2-s2.0-24144502074 10.1089/ars.2005.7.1337 (Pubitemid 41232531)
17. Gill P. S., Wilcox C. S., NADPH oxidases in the kidney. Antioxidants and Redox Signaling 2006 8 9-10 1597 1607 2-s2.0-33750919240 10.1089/ars.2006.8.1597 (Pubitemid 44726334)
18. Touyz R. M., Reactive oxygen species and angiotensin II signaling in vascular cells: implications in cardiovascular disease. Brazilian Journal of Medical and Biological Research 2004 37 8 1263 1273 2-s2.0-4444333896 (Pubitemid 39172561)
19. Zhong N., Xu J., Synergistic activation of the human MnSOD promoter by DJ-1 and PGC-1 α: regulation by SUMOylation and oxidation. Human Molecular Genetics 2008 17 21 3357 3367 2-s2.0-54449096831 10.1093/hmg/ddn230
20. Madsen-Bouterse S. A., Zhong Q., Mohammad G., Ho Y. S., Kowluru R. A., Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase. Free Radical Research 2010 44 3 313 321 2-s2.0-77249096912 10.3109/10715760903494168
21. Schmid U., Stopper H., Schweda F., Queisser N., Schupp N., Angiotensin II induces DNA damage in the kidney. Cancer Research 2008 68 22 9239 9246 2-s2.0-56449128693 10.1158/0008-5472.CAN-08-1310
22. Field L. J., Gross K. W., Ren -1 and Ren -2 loci are expressed in mouse kidney. Proceedings of the National Academy of Sciences of the United States of America 1985 82 18 6196 6200 2-s2.0-0022343497 (Pubitemid 16223925)
23. Arruda R. M., Peotta V. A., Meyrelles S. S., Vasquez E. C., Evaluation of vascular function in apolipoprotein E knockout mice with angiotensin-dependent renovascular hypertension. Hypertension 2005 46 4 932 936 2-s2.0-33644654332
24. Campagnaro B. P., Gava A. L., Meyrelles S. S., Cardiac-autonomic imbalance and baroreflex dysfunction in the renovascular angiotensin-dependent hypertensive mouse. International Journal of Hypertension 2012 2012 9 968123 10.1155/2012/968123
25. Singh N. P., McCoy M. T., Tice R. R., Schneider E. L., A simple technique for quantitation of low levels of DNA damage in individual cells. Experimental Cell Research 1988 175 1 184 191 2-s2.0-0023919963
26. Collins A. R., Dusinska M., Franklin M., Comet assay in human biomonitoring studies: reliability, validation, and applications. Environmental and Molecular Mutagenesis 1997 30 2 139 146 (Pubitemid 27440590)
27. da Silva J., Herrmann S. M., Heuser V., Peres W., Possa Marroni N., González-Gallego J., Erdtmann B., Evaluation of the genotoxic effect of rutin and quercetin by comet assay and micronucleus test. Food and Chemical Toxicology 2002 40 7 941 947 2-s2.0-0036282183 10.1016/S0278-6915(02)00015-7 (Pubitemid 34626702)
28. Wiesel P., Mazzolai L., Nussberger J., Pedrazzini T., Two-kidney, one-clip and one-kidney, one-clip hypertension in mice. Hypertension 1997 29 4 1025 1030 2-s2.0-0030940061 (Pubitemid 27152476)
29. Madeddu P., Milia A. F., Salis M. B., Gaspa L., Gross W., Lippoldt A., Emanueli C., Renovascular hypertension in bradykinin B2-receptor knockout mice. Hypertension 1998 32 3 503 509 2-s2.0-0031711539 (Pubitemid 28429140)
30. Hiyoshi H., Yayama K., Takano M., Okamoto H., Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with two-kidney, one-clip hypertension. Hypertension 2005 45 5 967 973 2-s2.0-18244408802 10.1161/01.HYP.0000164571.77710.19 (Pubitemid 40628945)
31. Lazartigues E., Lawrence A. J., Lamb F. S., Davisson R. L., Renovascular hypertension in mice with brain-selective overexpression of AT1a receptors is buffered by increased nitric oxide production in the periphery. Circulation Research 2004 95 5 523 531 2-s2.0-4444267418 10.1161/01.RES.0000140892.86313.c2 (Pubitemid 39193248)
32. Cervenka L., Vaneckova I., Huskova Z., Pivotal role of AT1 receptors in the development of two-kidney, one-clip hypertension: study in AT1 receptor knockout mice. Journal of Hypertension 2008 26 7 1379 1389 10.1097/HJH. 0b013e3282fe6eaa
33. Bell D., Kelso E. J., Argent C. C., Temporal characteristics of cardiomyocyte hypertrophy in the spontaneously hypertensive rat. Cardiovascular Pathology 2004 13 2 71 78 10.1016/S1054-8807(03)00135-2 (Pubitemid 38366424)
34. Lee T. M., Lin M. S., Tsai C. H., Chang N. C., Effect of pravastatin on left ventricular mass in the two-kidney, one-clip hypertensive rats. American Journal of Physiology 2006 291 6 H2705 H2713 2-s2.0-33845439989 10.1152/ajpheart.00224.2006 (Pubitemid 44904070)
35. Oro C., Qian H., Thomas W. G., Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. Pharmacology and Therapeutics 2007 113 1 210 226 2-s2.0-33845693028 10.1016/j.pharmthera.2006.10.001 (Pubitemid 44969930)
36. Barry S. P., Davidson S. M., Townsend P. A., Molecular regulation of cardiac hypertrophy. The International Journal of Biochemistry and Cell Biology 2008 40 10 2023 2039 2-s2.0-47649111868 10.1016/j.biocel.2008.02.020
37. Dzau V. J., Vascular renin-angiotensin system in hypertension. New insights into the mechanism of action of angiotensin converting enzyme inhibitors. The American Journal of Medicine 1988 84 4 4 8 2-s2.0-0023769282
38. Haznedaroglu I. C., Tuncer S., Gursoy M., A local renin-angiotensin system in the bone marrow. Medical Hypothesis 1996 46 6 507 510 10.1016/S0306-9877(96)90122-X (Pubitemid 26184769)
39. Rodgers K. E., Xiong S., Steer R., Effect of angiotensin-II on hematopoietic progenitor cell proliferation. Stem Cells 2000 18 4 287 294 10.1634/stemcells.18-4-287 (Pubitemid 30602276)
40. Endtman C., Ebrahimian T., Czech T., Angiotensin II impairs endothelial progenitor cell number and function in vitro and in vivo: implications for vascular regeneration. Hypertension 2011 58 3 394 403 10.1161/HYPERTENSIONAHA. 110.169193
41. Kato H., Ishida J., Imagawa S., Saito T., Suzuki N., Matsuoka T., Sugaya T., Tanimoto K., Yokoo T., Ohneda O., Sugiyama F., Yagami K. I., Fujita T., Yamamoto M., Nangaku M., Fukamizu A., Enhanced erythropoiesis mediated by activation of the renin-angiotensin system via angiotensin II type 1A receptor. The FASEB Journal 2005 19 14 2023 2025 2-s2.0-28744449602 10.1096/fj.05-3820fje (Pubitemid 41759752)
42. de la Iglesia Inigo S., López-Jorge C. E., Gómez-Casares M. T., Induction of apoptosis in leukemic cell lines treated with captopril, trandolapril and losartan: a new role in the treatment of leukaemia for these agents. Leukemia Research 2009 33 6 810 816 10.1016/j.leukres.2008.09.029
43. Ismail A., Khosravi H., Olson H., The tole of infection in atherosclerosis and coronary artery disease: a new therapeutic target. Heart Disease 1999 1 4 233 240 2-s2.0-0033188294
44. Ruiz-Ortega M., Lorenzo O., Suzuki Y., Rupérez M., Egido J., Proinflammatory actions of angiotensins. Current Opinion in Nephrology and Hypertension 2001 10 3 321 329 2-s2.0-0035022842 10.1097/00041552-200105000- 00005 (Pubitemid 32424019)
45. Schmidt-Ott K. M., Kagiyama S., Phillips M. I., The multiple actions of angiotensin II in atherosclerosis. Regulatory Peptides 2000 93 1-3 65 77 2-s2.0-0034714978 10.1016/S0167-0115(00)00178-6
46. Rueckschloss U., Quinn M. T., Holtz J., Morawietz H., Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arteriosclerosis, Thrombosis, and Vascular Biology 2002 22 11 1845 1851 2-s2.0-0036845042 10.1161/01.ATV.0000035392.38687.65 (Pubitemid 35315771)
47. Pueyo M. E., Gonzalez W., Nicoletti A., Savoie F., Arnal J. F., Michel J. B., Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor- B activation induced by intracellular oxidative stress. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 3 645 651 2-s2.0-0034060298 (Pubitemid 30151676)
48. Cassis L. A., Rateri D. L., Lu H., Daugherty A., Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 2 380 386 2-s2.0-33846444939 10.1161/01.ATV.0000254680.71485.92 (Pubitemid 46143055)
49. Fandrey J., Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. American Journal of Physiology 2004 286 6 R977 R988 2-s2.0-2442693041 10.1152/ajpregu.00577.2003 (Pubitemid 38661383)
50. da Cunha V., Tham D. M., Martin-McNulty B., Deng G., Ho J. J., Wilson D. W., Rutledge J. C., Vergona R., Sullivan M. E., Wang Y. X., Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis 2005 178 1 9 17 2-s2.0-10044221986 10.1016/j.atherosclerosis. 2004.08.023 (Pubitemid 39600810)
51. Giles T. D., Sander G. E., Nossaman B. D., Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors and prostaglandins. Journal of Clinical Hypertension 2012 14 4 198 205 10.1111/j.1751-7176.2012.00606.x
52. Khan S. R., Is oxidative stress a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urological Research 2012 40 2 95 112 10.1007/s00240-011-0448-9
53. Montezano A. C., Touyz R. M., Molecular mechanisms of hypertension-reactive oxygen species and antioxidants: a basic science update for the clinician. The Canadian Journal of Cardiology 2012 28 3 188 195
54. Campos R. R., Oliveira-Sales E. B., Nishi E. E., Boim M. A., Dolnikoff M. S., Bergamaschi C. T., The role of oxidative stress in renovascular hypertension. Clinical and Experimental Pharmacology and Physiology 2011 38 2 144 152 2-s2.0-79251485685 10.1111/j.1440-1681.2010.05437.x
55. Chan Y. C., Leung O. S., The renin-angiotensin system and reactive oxygen species: implications in pancreatitis. Antioxidants and Redox Signaling 2011 15 10 2743 2755 10.1089/ars.2011.4071
56. Oliveira-Sales E. B., Nishi E. E., Carillo B. A., Boim M. A., Dolnikoff M. S., Bergamaschi C. T., Campos R. R., Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. American Journal of Hypertension 2009 22 5 484 492 2-s2.0-67349247022 10.1038/ajh.2009.17
57. Braga V. A., Medeiros I. A., Ribeiro T. P., Angiotensin II-induced reactive oxygen species along the SFO-PVN-RVLM pathway: implications in neurogenic hypertension. Brazilian Journal of Medical and Biological Research 2011 44 9 871 876 10.1590/S0100-879X2011007500088
58. Wind S., Beuerlein K., Eucker T., Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. British Journal of Pharmacology 2010 161 4 885 898 10.1111/j.1476-5381.2010.00920.x
59. Beswick R. A., Dorrance A. M., Leite R., Webb R. C., NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 2001 38 5 1107 1111 2-s2.0-0035725015 (Pubitemid 34252814)
60. Dobrian A. D., Schriver S. D., Prewitt R. L., Role of angiotensin II and free radicals in blood pressure regulation in a rat model of renal hypertension. Hypertension 2001 38 3 361 366 2-s2.0-0035571514 (Pubitemid 34225666)
61. Griendling K. K., Minieri C. A., Ollerenshaw J. D., Alexander R. W., Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circulation Research 1994 74 6 1141 1148 2-s2.0-0028365310 (Pubitemid 24176909)
62. Higashi Y., Sasaki S., Nakagawa K., Matsuura H., Oshima T., Chayama K., Endothelial function and oxidative stress in renovascular hypertension. The New England Journal of Medicine 2002 346 25 1954 1962 2-s2.0-0037142088 10.1056/NEJMoa013591 (Pubitemid 34651355)
63. Touyz R. M., Tabet F., Schiffrin E. L., Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Clinical and Experimental Pharmacology and Physiology 2003 30 11 860 866 2-s2.0-0344304669 10.1046/j.1440-1681.2003.03930.x (Pubitemid 37506154)
64. Álvarez Y., Briones A. M., Hernanz R., Pérez-Girón J. V., Alonso M. J., Salaices M., Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats. British Journal of Pharmacology 2008 153 5 926 935 2-s2.0-40149097151 10.1038/sj.bjp.0707575 (Pubitemid 351328931)
65. Griendling K. K., Fitzgerald G. A., Oxidative stress and cardiovascular injury-part I: basic mechanisms and in vivo monitoring of ROS. Circulation 2003 108 16 1912 1916 2-s2.0-0142055950 10.1161/01.CIR.0000093660.86242.BB (Pubitemid 37296532)
66. Griendling K. K., Fitzgerald G. A., Oxidative stress and cardiovascular Injury-part II: animal and human studies. Circulation 2003 108 17 2034 2040 2-s2.0-0242349764 10.1161/01.CIR.0000093661.90582.c4 (Pubitemid 37337574)
67. Kimura S., Zhang G. X., Abe Y., Malfunction of vascular control in lifestyle-related diseases: oxidative stress of angiotensin II-induced hypertension: mitogen-activated protein kinases and blood pressure regulation. Journal of Pharmacological Sciences 2004 96 4 406 410 2-s2.0-12444257759 10.1254/jphs.FMJ04006X5 (Pubitemid 40144060)
68. Imanishi T., Hano T., Nishio I., Angiotensin II accelarates endothelial progenitor cell senescence through induction of oxidative stress. Journal of Hypertension 2005 23 1 97 104 2-s2.0-12344256734 10.1097/00004872-200501000- 00018 (Pubitemid 40128986)
69. Guzik T. J., Hoch N. E., Brown K. A., McCann L. A., Rahman A., Dikalov S., Goronzy J., Weyand C., Harrison D. G., Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction. Journal of Experimental Medicine 2007 204 10 2449 2460 2-s2.0-34948825774 10.1084/jem.20070657 (Pubitemid 47529329)
70. Valko M., Rhodes C. J., Moncol J., Izakovic M., Mazur M., Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions 2006 160 1 1 40 2-s2.0-32444433202 10.1016/j.cbi.2005.12.009 (Pubitemid 43227479)
71. Halliwell B., Aruoma O. I., DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems. FEBS Letters 1991 281 1-2 9 19 2-s2.0-0025972738 10.1016/0014-5793(91)80347-6
72. Andreassi M. G., Botto N., Simi S., Casella M., Manfredi S., Lucarelli M., Venneri L., Biagini A., Picano E., Diabetes and chronic nitrate therapy as co-determinants of somatic DNA damage in patients with coronary artery disease. Journal of Molecular Medicine 2005 83 4 279 286 2-s2.0-18744391953 10.1007/s00109-005-0634-8 (Pubitemid 40674954)
73. - and wild-type mice. Mutagenesis 2007 22 2 105 110 2-s2.0-33847617881 10.1093/mutage/gel059 (Pubitemid 46364515)
74. Dalboni S. P., Campagnaro B. P., Tonini C. L., The concurrence of hypercholesterolemia and aging promotes DNA damage in apolipoprotein E-deficient mice. Open Journal of Blood Diseases 2012 2 51 55 10.4236/ojbd.2012.23010
75. Schupp N., Kolkhof P., Queisser N., Gärtner S., Schmid U., Kretschmer A., Hartmann E., Oli R. G., Schäfer S., Stopper H., Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats. The FASEB Journal 2011 25 3 968 978 2-s2.0-79954571357 10.1096/fj.10-173286
76. Lee J., Lee M., Kim J. U., Song K. I., Choi Y. S., Cheong S. S., Carvedilol reduces plasma 8-hydroxy- 2 ′ -deoxyguanosine in mild to moderate hypertension: a pilot study. Hypertension 2005 45 5 986 990 2-s2.0-18244384044 10.1161/01.HYP.0000164569.63160.24 (Pubitemid 40628948)
77. Schupp N., Schmid U., Rutkowski P., Lakner U., Kanase N., Heidland A., Stopper H., Angiotensin II-induced genomic damage in renal cells can be prevented by angiotensin II type 1 receptor blockage or radical scavenging. American Journal of Physiology 2007 292 5 F1427 F1434 2-s2.0-34247847692 10.1152/ajprenal.00458.2006 (Pubitemid 46701870)
78. Cadet J., Douki T., Gasparutto D., Ravanat J. L., Oxidative damage to DNA: formation, measurement and biochemical features. Mutation Research 2003 531 1-2 5 23 2-s2.0-0344154463 10.1016/j.mrfmmm.2003.09.001 (Pubitemid 37456721)
79. Chen J., Chen W., Zhu M., Propofol attenuates angiotensin II-induced apoptosis in human coronary artery endothelial cells. British Journal of Anaesthesia 2012 107 4 525 532